Camilla C. Collet assists Danish and international Life Sciences companies with M&A transactions, commercial contracts, reorganisations and other transactions, often of an international nature and where the understanding of commercial principles is paramount.
Camilla has particular expertise in the Life Sciences segment where she has assisted with numerous acquisitions, sales and investments in life sciences companies. She advises pharmaceutical companies, biotech companies and manufacturers of medical devices on a current basis.
As head of our Compliance & CSR cross-practice group, Camilla advises on anti-corruption, export control, sanctions and business ethics, among other things.
Finally, Camilla has experience with board duties and regularly lectures on M&A, Contracts and Compliance.